TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial
Authors
Keywords
Carcinoma, Liver, Treatment, Sorafenib
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 74, Issue 5, Pages 947-954
Publisher
Springer Nature
Online
2014-08-30
DOI
10.1007/s00280-014-2568-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- Sorafenib enhances effects of transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis
- (2014) Qi-Han Fu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Combination Therapy of Sorafenib and TACE for Unresectable HCC: A Systematic Review and Meta-Analysis
- (2014) Lei Liu et al. PLoS One
- The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma
- (2012) Xu-Dong Qu et al. BMC CANCER
- Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma
- (2012) Joong-Won Park et al. JOURNAL OF HEPATOLOGY
- Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial
- (2012) D. Sansonno et al. ONCOLOGIST
- Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib
- (2012) Matthias Pinter et al. RADIOLOGY
- Perspectives on The Design of Clinical Trials Combining Transarterial Chemoembolization and Molecular Targeted Therapy
- (2012) Chiun Hsu et al. Liver Cancer
- Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
- (2011) Masatoshi Kudo et al. EUROPEAN JOURNAL OF CANCER
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma
- (2011) Timothy M. Pawlik et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Doxorubicin Plus Sorafenib vs Doxorubicin Alone in Patients With Advanced Hepatocellular Carcinoma
- (2010) Ghassan K. Abou-Alfa et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Colorectal cancer
- (2010) David Cunningham et al. LANCET
- The role of signaling pathways in the development and treatment of hepatocellular carcinoma
- (2010) S Whittaker et al. ONCOGENE
- Continuous Administration of Sorafenib in Combination with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Results of a Phase I Study
- (2010) J.-F. Dufour et al. ONCOLOGIST
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- (2009) Johannes Lammer et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
- (2009) Sean F. Altekruse et al. JOURNAL OF CLINICAL ONCOLOGY
- Multimodal approaches to the treatment of hepatocellular carcinoma
- (2009) Giuseppe Cabibbo et al. Nature Reviews Gastroenterology & Hepatology
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now